Fukuyama, Japan

Satoshi Hibino


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Satoshi Hibino

Introduction: Satoshi Hibino, an accomplished inventor based in Fukuyama, Japan, stands out in the realm of pharmaceutical innovations. With a portfolio of two patents, his work primarily focuses on novel compounds with significant therapeutic potential.

Latest Patents: Among his latest innovations are two notable patents: the "Progesterone Compound and Use Thereof" and a series of "Carbazole Compounds." The latter includes compounds characterized by the formula ##STR1## where specific configurations of carbon atoms and branches facilitate their strong antipsychotic activity. This innovative approach to pharmacology represents a substantial step forward in addressing mental health challenges.

Career Highlights: Throughout his career, Satoshi Hibino has contributed to significant advancements in the pharmaceutical industry. His work at companies such as Taisho Pharmaceutical Co., Ltd. and Meiji Milk Products Company, Limited has positioned him as a valuable asset in developing critical therapeutic compounds.

Collaborations: Satoshi has collaborated with notable professionals in his field, including Atsuro Nakazato and Sanae Kitsukawa. These collaborations have fostered an environment of innovation, leading to groundbreaking developments in the compounds he has focused on.

Conclusion: Satoshi Hibino exemplifies the dedication and ingenuity of inventors in the pharmaceutical sector. His patents not only enhance our understanding of chemical compounds but also contribute to the betterment of mental health therapies. As he continues to innovate, the impact of his work will undoubtedly resonate within the scientific community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…